Coherus: Interchangeability ‘A Melting Ice Cube,’ Price And Supply Key

FDA-Approved Yusimry Biosimilar Device ‘Will Look Nearly Identical’

Ice Cube Melting
Coherus wants to capture at least a 10% volume share • Source: Alamy

More from Biosimilars

More from Products